Welcome to our dedicated page for Solesence news (Ticker: SLSN), a resource for investors and traders seeking the latest updates and insights on Solesence stock.
Solésence, Inc. (Nasdaq: SLSN) is a scientifically driven health care solutions company in the household and personal products space, focused on beauty and life science categories. Company news frequently centers on its mineral-based skin care, sun care and color cosmetics activities, which it positions around skin health, aesthetics and daily wearability.
Investors following SLSN news can expect regular updates on financial performance, including quarterly earnings results, revenue trends and gross margin commentary, as reflected in the company’s first, second and third quarter 2025 press releases. These announcements often discuss shipment and production volumes, non-GAAP measures such as adjusted EBITDA, and the impact of operational changes on profitability.
Solésence also issues news about corporate developments, such as its rebranding from Nanophase Technologies to Solésence, its uplisting to Nasdaq under the SLSN ticker, and its inclusion in the Russell 3000 and Russell 2000 indexes. Leadership changes are another recurring theme, including the promotion of Kevin Cureton to President and Chief Executive Officer, the appointment of Laura Riffner as Chief Financial Officer, and the creation of a Vice President of Innovation and Product Integrity role.
Operational and strategic updates appear in releases about manufacturing consolidation, increased automation, expanded debt facilities, and the unification of research and development, product development, regulatory and quality functions. For those tracking the intersection of beauty and skin health, Solésence news also highlights intellectual property milestones and recognition within the beauty industry. This page aggregates such company-issued information so readers can monitor how Solésence describes its progress and strategic direction over time.
Solésence (Nasdaq: SLSN) announced on February 26, 2026 that Yoolie Park has been appointed Vice President of Brand Partnerships. Park brings over 20 years of beauty packaging and brand relationship experience and will lead strategic partnerships to expand turnkey solutions and accelerate brand speed to market.
Park joins from Paklab and previously held leadership roles at APG, IPKG, and Nestfiller. Management highlights her expertise in packaging and indie brand relationships as a driver of innovation and partner growth.
Solésence (Nasdaq: SLSN) reported third quarter 2025 results for the period ended September 30, 2025, highlighting an ongoing strategic transformation with executive promotions and operational consolidation.
Key financials: Revenue $14.5M vs $16.9M a year earlier; Gross margin 23% vs 36% prior year; Gross profit $3.4M vs $6.1M; Net loss $1.1M vs net income $3.0M. Operational moves include consolidating manufacturing from three facilities to two, increased automation, and a unified R&D/product/quality group. Company appointed Kevin Cureton as CEO, Laura Riffner as CFO, and Yoana Dvorzsak to lead innovation and product integrity. A conference call was scheduled for Nov 11, 2025 at 8:30 a.m. ET.
Solésence (Nasdaq: SLSN) on November 10, 2025 appointed Yoana Dvorzsak as Vice President of Innovation and Product Integrity. In the newly created role she will lead a unified group combining research & development, product and component development, regulatory, and quality operations to drive efficiency, uphold product performance and compliance, and reduce operating costs.
Dvorzsak is co‑founder of Solésence's consumer products line, has led dozens of client programs from concept to launch, and was named a 2025 CEW Innovator Honoree. Management says the move aims to accelerate innovation and strengthen product integrity across skin care, sun care, and color cosmetics for brand partners and consumers.
Solésence (Nasdaq: SLSN) will report third quarter 2025 financial results before market open on Tuesday, November 11, 2025 and will host a conference call and webcast the same day.
The conference call is scheduled for 7:30 a.m. CDT / 8:30 a.m. EDT and will feature Kevin Cureton, President & CEO; Laura Riffner, CFO; and Jess Jankowski, Board Advisor. A live webcast will be available and a dial-in requires registration to receive a personalized PIN and optional dial-out.
Investors are advised to register in advance and join at least five minutes early; the webcast will also be posted on the company's investor relations website.
Solésence (NASDAQ:SLSN) announced significant leadership changes as part of its strategic transformation. Kevin Cureton has been promoted to President and CEO, while Laura Riffner joins as CFO. Current CEO Jess Jankowski will transition to Board Advisor until his retirement on November 21, 2025.
These appointments follow Solésence's recent rebranding from Nanophase Technologies and uplisting to Nasdaq in early 2025. The company, which transformed from an advanced materials company to a skin health innovator, specializes in mineral-based sun protection and beauty science solutions.
Riffner brings over 35 years of finance experience, including significant tenure as CFO at Nagase America. The leadership changes aim to build on the company's momentum in delivering skin care, sun care, and color cosmetics products globally.
Solésence (NASDAQ:SLSN) reported strong financial results for Q2 2025, with revenue surging 56% to $20.4 million compared to Q2 2024. The company achieved a net income of $2.7 million, which includes a $1.2 million Employee Retention Credit.
Operational highlights include significant volume growth, with shipments up 102% and production volume increasing 127% year-over-year. The company expanded its debt facilities, increasing maximum borrowing capacity from $14.2 million to $23.0 million and extending loan maturity dates to April 2027.
The company maintained a stable gross margin of 29% and was added to the Russell 3000® and Russell 2000® indexes, marking significant institutional recognition.
Solésence (Nasdaq: SLSN), a leader in scientifically-driven healthcare solutions for beauty and life science categories, has scheduled its second quarter 2025 financial results announcement for Thursday, July 31, 2025, after market close.
The company will host a conference call and webcast on the same day at 4:00 p.m. CDT (5:00 p.m. EDT). The call will feature presentations from President & CEO Jess Jankowski and COO Kevin Cureton. Participants can access the event through the company's investor relations website or register for dial-in access.
Solésence (Nasdaq: SLSN), a healthcare solutions provider specializing in beauty and life science, has announced its upcoming inclusion in both the Russell 3000® and Russell 2000® Indexes, effective June 30, 2025. This milestone follows the company's recent Nasdaq uplisting and is part of the 2025 Russell indexes reconstitution.
The inclusion is based on FTSE Russell's objective market-capitalization rankings, which capture the 4,000 largest US stocks as of April 30. This development is particularly significant as approximately $10.6 trillion in assets are benchmarked against Russell US indexes, potentially increasing Solésence's visibility among institutional investors.